Malignant Neuroleptic Syndrome: Difference between revisions
Jump to navigation
Jump to search
Ttenbergen (talk | contribs) mNo edit summary |
Ttenbergen (talk | contribs) m Text replacement - "Neurologic" to "Neurological Problem" |
||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
{{DX tag | | {{DX tag | Neurological Problem | Medical Problem| Malignant Neuroleptic Syndrome (MNS) | MALIGNANT NEUROLEPTIC SYNDROME | 51900 - Malignant Neuroleptic Syndrome | No | 0 | CC&Med | Currently Collected | | }} | ||
{{PreICD10 dx | NewDxArticle = Neuroleptic malignant syndrome }} | |||
Go to: [http://en.wikipedia.org/wiki/Neuroleptic_malignant_syndrome Wikipedia-Malignant Neuroleptic Syndrome] for more information. | Go to: [http://en.wikipedia.org/wiki/Neuroleptic_malignant_syndrome Wikipedia-Malignant Neuroleptic Syndrome] for more information. |
Latest revision as of 21:15, 2018 December 30
Legacy Content
This page is about the pre-ICD10 diagnosis coding schema. See the ICD10 Diagnosis List, or the following for similar diagnoses in ICD10:Neuroleptic malignant syndromeClick Expand to show legacy content.
edit dx infobox | |
Category/Organ System: |
Category: Neurological Problem (old) |
Type: |
|
Main Diagnosis: | Malignant Neuroleptic Syndrome (MNS) |
Sub Diagnosis: | MALIGNANT NEUROLEPTIC SYNDROME |
Diagnosis Code: | 51900 - Malignant Neuroleptic Syndrome |
Comorbid Diagnosis: | No |
Charlson Comorbid coding (pre ICD10): | 0 |
Program: | CC&Med |
Status: | Currently Collected
|
Go to: Wikipedia-Malignant Neuroleptic Syndrome for more information.
- MNS is an adverse reaction to neuroleptic or antipsychotic drugs characterized by F E V E R:
- F =Temp>38
- E=Encephalopathy
- V=Vitals signs are unstable
- E =Elevated CPKs
- R=Rigidity muscles
Drugs such as Haldol, Chlorpromazine, Metoclopramides, Lithium,and antiparkinson drugs Levodopa can cause MNS.
If MNS is coded, don't also code Other overdose - Accidental toxicity-other drugs as this would be redundant as it would not give us any additional data.